CClinicalTrials.gg
CompletedNCT00296751Updated Jul 1, 2010

Epidural Analgesia Versus IV Meperidine for Labor Pain Control

An interventional study of ECG recording and Epidural catheter insertion in Labor Pain, sponsored by Rambam Health Care Campus. Completed at 1 site in Israel. Open to female participants aged 20 Years to 40 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2010-07-01.

Sponsored by Rambam Health Care Campus · Not applicable and Interventional

Phase
Not applicable
Study type
Interventional
Enrollment
60
Allocation
Randomized
Ages
20 Years to 40 Years
Sex
Female
01

Study summary

60 female that care for pain control during second stage of delivery, will choose between epidural or systemic analgesia. Continuous ECG (3 lead)monitoring will be recorded during the second stage for 10 minutes. 30 minutes after administration of either pain relief, a second recording of maternal ECG will take place for 10 minutes.

Read the detailed description

Population 60 female during second stage of delivery

  • Inclusion criteria : all parturients requiring pain relief will choose between systemic or epidural analgesia.
  • Exclusion Criteria: all parturients with cardiac disease, neurological disease, endocrine disease, diabetes, hypertension or any parturients being treated with medications that might effect the cardiovascular autonomic system.
  • Method: A 10 minute recording of a 3 lead ECG will be performed during the second stage of the delivery (3-7 CM opening).

the parturient will be lying on her left side for that period.

  • 30 minutes after administration of either epidural or systemic Meperidine for pain relief, a second recording of maternal ECG will take place for 10 minutes.
  • estimated duration of the procedure about one hour per woman.
02

Conditions studied

  • Labor Pain

Browse trials for

03

In context

Labor Pain

396 studies on the registry are indexed under Labor Pain; 66 are open to participants now.

This study's planned enrollment of 60 is below the median of 100 across 325 interventional studies indexed under Labor Pain.

Browse Labor Pain studies →

Lead sponsor

Rambam Health Care Campus is the lead sponsor of 456 studies on the registry; 33 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
20 Years to 40 Years
Sexes eligible
Female
Accepts healthy volunteers
Yes

Eligibility criteria

Inclusion Criteria: all parturients requiring pain relief will choose between systemic or epidural analgesia.

Exclusion Criteria: all parturients with cardiac disease, neurological disease, endocrine disease, diabetes, hypertension or any parturients being treated with medications that might effect the cardiovascular or autonomic system.

-

05

Study design

Phase
Not applicable
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
60 participants (estimated)

Interventions

  • ProcedureECG recording
  • ProcedureEpidural catheter insertion
  • DrugIntravenous meperidine injection
  • DrugEpidural Bupivacaine and fentanyl injection
06

What researchers measure

Primary outcomes

  1. Three lead ECG monitoring for 10 minutes will be performed 30 minutes after the administration.

07

Study locations

1 site
  • Rambam - health care campus
    Haifa, 31096, Israel
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jul 1, 2010, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT00296751
Lead sponsor
Rambam Health Care Campus
First posted
Feb 27, 2006
Start date
Mar 2006
Primary completion
Dec 2006
Completion
Dec 2006
Last update
Jul 1, 2010

Study contacts

Amir Weissman, MD
study director · Rambam Health Care Campus
Olga Torchov, MD
principal investigator · Rambam Health Care Campus
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Apr 2008. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion